TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alzamend Neuro ( (ALZN) ) has provided an announcement.
Between October 1 and October 8, 2025, Alzamend Neuro, Inc. issued 361,743 shares of common stock following the conversion of 839.2 shares of Series B Convertible Preferred Stock. This issuance increased the company’s total outstanding common stock to 3,801,604 shares, reflecting a strategic financial maneuver that could impact its market positioning and shareholder value.
The most recent analyst rating on (ALZN) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Alzamend Neuro stock, see the ALZN Stock Forecast page.
More about Alzamend Neuro
Average Trading Volume: 156,728
Technical Sentiment Signal: Strong Sell
Current Market Cap: $7.82M
Find detailed analytics on ALZN stock on TipRanks’ Stock Analysis page.